Heart and Vascular
ActIn TrOPHy
Atrial Fibrillation
A Phase 1b/2, Multicenter, Double-Blind, Placebo-Controlled, Multiple Dose Study Assessing the Pharmacokinetics, Safety, Pharmacodynamics, and Efficacy of HS235 in Obese Participants with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction
Contact Research Team:
[email protected]
Site principal investigator:
Andrew Sauer, MD
Learn more about this study:
NCT07123779